Potential Methamphetamine Vaccine

  • Author: ChemistryViews
  • Published: 17 April 2011
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Journal of the American Chemical Society/ACS Publications
thumbnail image: Potential Methamphetamine Vaccine

(+)-Methamphetamine (METH) use and addiction has grown at alarming rates over the past two decades. Unlike heroin and its methadone treatment, no approved chemical substitute exists for treatment of METH addiction. Immunopharmacotherapy uses an alternative approach to treating addiction: vaccination leads to the production of antibodies that prevent drug distribution to brain receptors.


A series of small molecules that show promise as METH vaccines have been identified by Kim Janda and colleagues, Scripps Research Institute, California, USA. The team used molecular modeling to determine which structures would target the most stable conformations of methamphetamine. Initial tests in mice showed six of the structures were promising; they had high affinity for METH and produced antibody concentrations in the range 45−108 μg/mL.


Article Views: 2624

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH